Identification of casein kinase-1 phosphorylation sites on TDP-43

Biochemical and Biophysical Research Communications

Volumn 382, Issue 2, 2009, Pages 405-409

  Kametani, Fuyuki ^a   Nonaka, Takashi ^a   Suzuki, Takehiro ^b   Arai, Tetsuaki ^a   Dohmae, Naoshi ^b   Akiyama, Haruhiko ^a   Hasegawa, Masato ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Casein kinase 1; Frontotemporal lobar degeneration with ubiquitin positive inclusions; Mass spectrometry; Phosphorylation; TDP 43

Indexed keywords

CASEIN KINASE I; TAR DNA BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BINDING SITE; BRAIN; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS INCLUSION BODY; DNA BINDING; FRONTOTEMPORAL DEMENTIA; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION;

AMINO ACID SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN; CASEIN KINASE I; DEMENTIA; DNA-BINDING PROTEINS; HUMANS; INCLUSION BODIES; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PHOSPHOSERINE; RECOMBINANT PROTEINS; SERINE;

EID: 63349083295     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.038     Document Type: Article

References (29)

1. Ou S.H., Wu F., Harrich D., Garcia-Martinez L.F., and Gaynor R.B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69 (1995) 3584-3596
2. Wang H.-Y., Wang I.F., Bose J., and Shen C.K.J. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83 (2004) 130-139
3. Buratti E., Dork T., Zuccato E., Pagani F., Romano M., and Baralle F.E. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20 (2001) 1774-1784
4. Bose J.K., Wang I.F., Hung L., Tarn W.-Y., and Shen C.K.J. TDP-43 overexpression enhances exon-7 inclusion during SMN Pre-mRNA splicing. J. Biol. Chem. 283 (2008) 28852-28859
5. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M.Y. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
6. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., and Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351 (2006) 602-611
7. Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach H.G., Buratti E., Baralle F.E., Morita M., Nakano I., Oda A., Tsuchiya K., and Akiyama H. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64 (2008) 60-70
8. Inukai Y., Nonaka T., Arai T., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F.E., Akiyama H., Hisanaga S., and Hasegawa M. Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS. FEBS Lett. 582 (2008) 2899-2904
9. Nonaka T., Arai T., Buratti E., Baralle F.E., Akiyama H., and Hasegawa M. Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett. 583 (2009) 394-400
10. Zhang X., Ye J., Jensen O.N., and Roepstorff P. Highly efficient phosphopeptide enrichment by calcium phosphate precipitation combined with subsequent IMAC enrichment. Mol. Cell. Proteomics 6 (2007) 2032-2042
11. Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., and Mann M. Global, in vivo and site-specific phosphorylation dynamics in signaling networks. Cell 127 (2006) 635-648
12. Blom N., Sicheritz-Ponten T., Gupta R., Gammeltoft S., and Brunak S. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 4 (2004) 1633-1649
13. NetPhosK server. Available from: http://www.cbs.dtu.dk/services/NetPhosK/.
14. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White III C.L., Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., and Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 63 (2008) 535-538
15. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., and Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319 (2008) 1668-1672
16. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.-P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.-F., Camu W., Meininger V., Dupre N., and Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 40 (2008) 572-574
17. Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., Steinbart E., McCluskey L., Grossman M., Neumann M., Wu I.L., Yang W.-S., Kalb R., Galasko D.R., Montine T.J., Trojanowski J.Q., Lee V.M.Y., Schellenberg G.D., and Yu C.-E. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol. 7 (2008) 409-416
18. Yokoseki A., Shiga A., Tan C.-F., Tagawa A., Kaneko H., Koyama A., Eguchi H., Tsujino A., Ikeuchi T., Kakita A., Okamoto K., Nishizawa M., Takahashi H., and Onodera O. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63 (2008) 538-542
19. Rutherford N.J., Zhang Y.-J., Baker M., Gass J.M., Finch N.A., Xu Y.-F., Stewart H., Kelley B.J., Kuntz K., Crook R.J.P., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L., and Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 4 (2008) e1000193
20. Kuhnlein P., Sperfeld A.D., Vanmassenhove B., Van Deerlin V., Lee V.M., Trojanowski J.Q., Kretzschmar H.A., Ludolph A.C., and Neumann M. Two German kindreds with familial amyotrophic lateral sclerosis due to TARDBP mutations. Arch. Neurol. 65 (2008) 1185-1189
21. L. Corrado, A. Ratti, C. Gellera, E. Buratti, B. Castellotti, Y. Carlomagno, N. Ticozzi, L. Mazzini, L. Testa, F. Taroni, F.E. Baralle, V. Silani, S.D. Alfonso, High frequency of TARDBP gene mutations in Italian patients with amyotrophic lateral sclerosis, Hum. Mutat., 2009, doi:10.1002/humu.20950.
22. Ayala Y.M., Pantano S., D'Ambrogio A., Buratti E., Brindisi A., Marchetti C., Romano M., and Baralle F.E. Human, Drosophila, and C. elegans TDP43: nucleic acid binding properties and splicing regulatory function. J. Mol. Biol. 348 (2005) 575-588
23. Mercado P.A., Ayala Y.M., Romano M., Buratti E., and Baralle F.E. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene. Nucl. Acids Res. 33 (2005) 6000-6010
24. Abhyankar M.M., Urekar C., and Reddi P.P. A novel CpG-free vertebrate insulator silences the testis-specific SP-10 gene in somatic tissues: role for TDP-43 in insulator function. J. Biol. Chem. 282 (2007) 36143-36154
25. Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y.M., and Baralle F.E. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 280 (2005) 37572-37584
26. Johnson B.S., McCaffery J.M., Lindquist S., and Gitler A.D. A yeast TDP-43 proteinopathy model: exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc. Natl. Acad. Sci. USA 105 (2008) 6439-6444
27. Neumann M., Kwong L.K., Lee E.B., Kremmer E., Flatley A., Xu Y., Forman M.S., Troost D., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117 (2009) 137-149
28. Hasegawa M., Jakes R., Crowther R.A., Lee V.M.Y., Ihara Y., and Goedert M. Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett. 384 (1996) 25-30
29. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., and Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4 (2002) 160-164